From alois to amyvid seeing alzheimer disease

Neurology

Volumn 79, Issue 16, 2012, Pages 1628-1629

  Furst, Ansgar J ^a,b   Kerchner, Geoffrey A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FLORBETAPIR F 18;

ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE; CLINICAL ASSESSMENT TOOL; CLINICAL DEMENTIA RATING SCALE SUM OF BOXES; DEMENTIA; EDITORIAL; HUMAN; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL;

EID: 84871239563     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182662084     Document Type: Editorial

References (10)

1. Alzheimer A.Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift Psychiatrie 1907;64:146-148.
2. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound B. Ann Neurol 2004;55:306-319.
3. Kerchner GA. Amyloid imaging for Alzheimer's disease. Expert Opin Med Diagn 2011;5:527-538.
4. Clark CM, Schneider JA, Bedell BJ, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 2011;305:275-283.
5. Doraiswamy PM, Sperling RA, Coleman RE, et al. Amyloid-assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology 2012;79:1636-1644.
6. Villemagne VL, Pike KE, Chetelat G, et al. Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Ann Neurol 2011;69:181-192.
7. Clark CM, Schneider JA, Bedell BJ, et al. Use of florbetapir-PET for imaging-amyloid pathology. JAMA 2011;305:275-283.
8. Camus V, Payoux P, Barre L, et al. Using PET with 18FAV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imaging 2012; 39:621-631.
9. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
10. Furst AJ, Rabinovici GD, Rostomian AH, et al. Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiol Aging 2012;33:215-225.